ArticleBMC cancer2024

Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma.

Ralf Gutzmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.